BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Teva
Harvard Business School
Deloitte
Colorcon
US Department of Justice
QuintilesIMS
McKesson
Baxter
Novartis

Generated: January 24, 2018

DrugPatentWatch Database Preview

PROPANTHELINE BROMIDE Drug Profile

« Back to Dashboard

Which patents cover Propantheline Bromide, and what generic alternatives are available?

Propantheline Bromide is a drug marketed by Ascot, Heather, Impax Labs, Mylan, Par Pharm, Pvt Form, Sandoz, Tablicaps, Watson Labs, and West-ward Pharms Int. and is included in eleven NDAs.

The generic ingredient in PROPANTHELINE BROMIDE is propantheline bromide. There are seven drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the propantheline bromide profile page.
Drug patent expirations by year for PROPANTHELINE BROMIDE
Pharmacology for PROPANTHELINE BROMIDE
Drug ClassAnticholinergic
Mechanism of ActionCholinergic Antagonists
Medical Subject Heading (MeSH) Categories for PROPANTHELINE BROMIDE

US Patents and Regulatory Information for PROPANTHELINE BROMIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ascot PROPANTHELINE BROMIDE propantheline bromide TABLET;ORAL 087663-001 Oct 25, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sandoz PROPANTHELINE BROMIDE propantheline bromide TABLET;ORAL 080928-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mylan PROPANTHELINE BROMIDE propantheline bromide TABLET;ORAL 083706-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
West-ward Pharms Int PROPANTHELINE BROMIDE propantheline bromide TABLET;ORAL 080927-002 Approved Prior to Jan 1, 1982 RX No Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Tablicaps PROPANTHELINE BROMIDE propantheline bromide TABLET;ORAL 084428-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Heather PROPANTHELINE BROMIDE propantheline bromide TABLET;ORAL 085780-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Impax Labs PROPANTHELINE BROMIDE propantheline bromide TABLET;ORAL 084541-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Pvt Form PROPANTHELINE BROMIDE propantheline bromide TABLET;ORAL 080977-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Par Pharm PROPANTHELINE BROMIDE propantheline bromide TABLET;ORAL 088377-001 Dec 8, 1983 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Watson Labs PROPANTHELINE BROMIDE propantheline bromide TABLET;ORAL 083151-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Moodys
Daiichi Sankyo
Novartis
Queensland Health
Teva
Cerilliant
Chubb
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot